02 Aug 2022 --- The US Food and Drug Administration (FDA) will exercise enforcement discretion for N-Acetyl-Cysteine (NAC), in products labeled as dietary supplements. After months of legal wrangling, the move was met with a slew of reactions, ranging from deeming it “bittersweet” to disagreeing with the agency’s interpretation.
